Cargando…
A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma
SIMPLE SUMMARY: Our analysis of a 17-gene expression signature resulted in being significantly different among patients with clear cell renal cancer cell (ccRCC) who reported a recurrence-free survival (RFS) >5 years and patients with a RFS < 1 year. This Genomic Signatures could be useful to...
Autores principales: | Bassanelli, Maria, Borro, Marina, Roberto, Michela, Giannarelli, Diana, Giacinti, Silvana, Di Martino, Simona, Ceribelli, Anna, Russo, Andrea, Aschelter, Annamaria, Scarpino, Stefania, Montori, Andrea, Pescarmona, Edoardo, Tomao, Silverio, Simmaco, Maurizio, Cognetti, Francesco, Milella, Michele, Marchetti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750239/ https://www.ncbi.nlm.nih.gov/pubmed/35008342 http://dx.doi.org/10.3390/cancers14010178 |
Ejemplares similares
-
Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma
por: Roberto, Michela, et al.
Publicado: (2015) -
Genomic and epigenomic alterations in prostate cancer
por: Aschelter, Anna M., et al.
Publicado: (2012) -
Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice
por: Roberto, Michela, et al.
Publicado: (2021) -
SARS-CoV-2 Transmission Control Measures in the Emergency Department: The Role of Rapid Antigenic Testing in Asymptomatic Subjects
por: Borro, Marina, et al.
Publicado: (2022) -
The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study
por: Roberto, Michela, et al.
Publicado: (2022)